『Drug Discovery AI Factory』
Utilizing KIBIT, we extract a large number of unreported target genes and further narrow them down to more reliable targets using our unique analysis method.
KIBIT generates a network that maps the connections between genes related to diseases. In doing so, it also predicts target genes that are not mentioned in the literature regarding their association with the disease. To extract high-probability targets from these target genes, it utilizes an innovative analysis method called "Drug Discovery Best Known Method (DD-BKM)" to narrow down to targets with a high potential for new drug development.
- Company：FRONTEO
- Price：Other
